nodes	percent_of_prediction	percent_of_DWPC	metapath
Dofetilide—CYP3A4—breast cancer	0.274	1	CbGaD
Dofetilide—CYP3A4—Exemestane—breast cancer	0.0573	0.133	CbGbCtD
Dofetilide—CYP3A4—Letrozole—breast cancer	0.0487	0.113	CbGbCtD
Dofetilide—CYP3A4—Anastrozole—breast cancer	0.0434	0.101	CbGbCtD
Dofetilide—CYP3A4—Toremifene—breast cancer	0.0397	0.0921	CbGbCtD
Dofetilide—CYP3A4—Fulvestrant—breast cancer	0.0369	0.0856	CbGbCtD
Dofetilide—CYP3A4—Thiotepa—breast cancer	0.0329	0.0763	CbGbCtD
Dofetilide—CYP3A4—Ixabepilone—breast cancer	0.0301	0.0698	CbGbCtD
Dofetilide—CYP3A4—Lapatinib—breast cancer	0.029	0.0672	CbGbCtD
Dofetilide—CYP3A4—Raloxifene—breast cancer	0.0219	0.0509	CbGbCtD
Dofetilide—CYP3A4—Vinorelbine—breast cancer	0.0161	0.0373	CbGbCtD
Dofetilide—CYP3A4—Tamoxifen—breast cancer	0.0145	0.0336	CbGbCtD
Dofetilide—CYP3A4—Mitoxantrone—breast cancer	0.0141	0.0328	CbGbCtD
Dofetilide—CYP3A4—Paclitaxel—breast cancer	0.0113	0.0262	CbGbCtD
Dofetilide—CYP3A4—Irinotecan—breast cancer	0.0111	0.0258	CbGbCtD
Dofetilide—CYP3A4—Vinblastine—breast cancer	0.0099	0.023	CbGbCtD
Dofetilide—CYP3A4—Docetaxel—breast cancer	0.00816	0.0189	CbGbCtD
Dofetilide—CYP3A4—Doxorubicin—breast cancer	0.00608	0.0141	CbGbCtD
Dofetilide—KCNK2—mammary gland—breast cancer	0.00283	0.289	CbGeAlD
Dofetilide—Rosiglitazone—SLCO1B1—breast cancer	0.00212	0.392	CrCbGaD
Dofetilide—KCNK2—adipose tissue—breast cancer	0.00127	0.13	CbGeAlD
Dofetilide—KCNK2—adrenal gland—breast cancer	0.00114	0.117	CbGeAlD
Dofetilide—Rosiglitazone—PTGS1—breast cancer	0.000791	0.146	CrCbGaD
Dofetilide—KCNK2—lymph node—breast cancer	0.000684	0.07	CbGeAlD
Dofetilide—KCNH2—nipple—breast cancer	0.000652	0.0667	CbGeAlD
Dofetilide—Rosiglitazone—CYP2D6—breast cancer	0.000538	0.0995	CrCbGaD
Dofetilide—CYP3A4—Irinotecan Pathway—SLCO1B1—breast cancer	0.000521	0.0122	CbGpPWpGaD
Dofetilide—Dronedarone—CYP2D6—breast cancer	0.000468	0.0866	CrCbGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—BCHE—breast cancer	0.000462	0.0108	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—DLX2—breast cancer	0.000459	0.0107	CbGpPWpGaD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—SLCO1B1—breast cancer	0.000446	0.0104	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CXCR4—breast cancer	0.000434	0.0102	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—ACHE—breast cancer	0.000406	0.0095	CbGpPWpGaD
Dofetilide—Rosiglitazone—ALB—breast cancer	0.000403	0.0745	CrCbGaD
Dofetilide—Dronedarone—CYP3A4—breast cancer	0.000402	0.0742	CrCbGaD
Dofetilide—KCNH2—endometrium—breast cancer	0.000394	0.0403	CbGeAlD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—breast cancer	0.000384	0.00899	CbGpPWpGaD
Dofetilide—CYP3A4—Irinotecan Pathway—ABCC1—breast cancer	0.000381	0.00891	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNN4—breast cancer	0.000381	0.0089	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—COMT—breast cancer	0.000369	0.00863	CbGpPWpGaD
Dofetilide—KCNH2—uterus—breast cancer	0.000363	0.0371	CbGeAlD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—breast cancer	0.000361	0.00845	CbGpPWpGaD
Dofetilide—KCNH2—pituitary gland—breast cancer	0.000357	0.0365	CbGeAlD
Dofetilide—KCNJ12—Neuronal System—BCHE—breast cancer	0.000354	0.00827	CbGpPWpGaD
Dofetilide—Dronedarone—ALB—breast cancer	0.00035	0.0648	CrCbGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—STAT5A—breast cancer	0.00035	0.00818	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—ALDH3A2—breast cancer	0.000338	0.0079	CbGpPWpGaD
Dofetilide—Dronedarone—ABCB1—breast cancer	0.000334	0.0618	CrCbGaD
Dofetilide—KCNH2—female reproductive system—breast cancer	0.000326	0.0334	CbGeAlD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—CSF2—breast cancer	0.000325	0.00761	CbGpPWpGaD
Dofetilide—KCNH2—adrenal gland—breast cancer	0.000318	0.0326	CbGeAlD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—breast cancer	0.000313	0.00733	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HADHB—breast cancer	0.00031	0.00725	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—YBX1—breast cancer	0.00031	0.00725	CbGpPWpGaD
Dofetilide—KCNH2—bone marrow—breast cancer	0.000308	0.0315	CbGeAlD
Dofetilide—KCNH2—female gonad—breast cancer	0.000297	0.0304	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—THRB—breast cancer	0.000296	0.00692	CbGpPWpGaD
Dofetilide—CYP3A4—Liver X Receptor Pathway—FASN—breast cancer	0.000288	0.00673	CbGpPWpGaD
Dofetilide—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—breast cancer	0.000285	0.00667	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—COMT—breast cancer	0.000283	0.00661	CbGpPWpGaD
Dofetilide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—breast cancer	0.000279	0.00652	CbGpPWpGaD
Dofetilide—KCNH2—endocrine gland—breast cancer	0.000276	0.0282	CbGeAlD
Dofetilide—CYP3A4—Estrogen metabolism—SULT1A1—breast cancer	0.000274	0.00642	CbGpPWpGaD
Dofetilide—CYP3A4—Estrogen metabolism—GSTA1—breast cancer	0.000268	0.00627	CbGpPWpGaD
Dofetilide—CYP3A4—Irinotecan Pathway—ABCG2—breast cancer	0.000264	0.00618	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—breast cancer	0.000263	0.00614	CbGpPWpGaD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—breast cancer	0.000262	0.00612	CbGpPWpGaD
Dofetilide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—breast cancer	0.000258	0.00603	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—ACHE—breast cancer	0.000258	0.00603	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—PPARGC1B—breast cancer	0.000255	0.00597	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—NOTCH1—breast cancer	0.00025	0.00584	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—KCNH1—breast cancer	0.000245	0.00573	CbGpPWpGaD
Dofetilide—CYP3A4—Tamoxifen metabolism—SULT1A1—breast cancer	0.000243	0.00567	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—BRAF—breast cancer	0.000236	0.00551	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—FOS—breast cancer	0.000233	0.00545	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—BCHE—breast cancer	0.000225	0.00525	CbGpPWpGaD
Dofetilide—CYP3A4—Irinotecan Pathway—BCHE—breast cancer	0.000219	0.00512	CbGpPWpGaD
Dofetilide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—breast cancer	0.000216	0.00505	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.000215	0.00503	CbGpPWpGaD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—breast cancer	0.000208	0.00485	CbGpPWpGaD
Dofetilide—CYP3A4—female reproductive system—breast cancer	0.000202	0.0207	CbGeAlD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—MDM2—breast cancer	0.000197	0.00462	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—RAF1—breast cancer	0.000197	0.0046	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.000194	0.00453	CbGpPWpGaD
Dofetilide—KCNH2—lymph node—breast cancer	0.000191	0.0195	CbGeAlD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000183	0.00427	CbGpPWpGaD
Dofetilide—KCNJ12—Neuronal System—BRAF—breast cancer	0.000181	0.00422	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—COMT—breast cancer	0.00018	0.0042	CbGpPWpGaD
Dofetilide—Hyperhidrosis—Gemcitabine—breast cancer	0.000178	0.000749	CcSEcCtD
Dofetilide—Dizziness—Tamoxifen—breast cancer	0.000177	0.000746	CcSEcCtD
Dofetilide—Migraine—Epirubicin—breast cancer	0.000176	0.000743	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—breast cancer	0.000175	0.0041	CbGpPWpGaD
Dofetilide—Oedema peripheral—Capecitabine—breast cancer	0.000175	0.000738	CcSEcCtD
Dofetilide—Diarrhoea—Goserelin—breast cancer	0.000175	0.000737	CcSEcCtD
Dofetilide—CYP3A4—Xenobiotics—CYP2D6—breast cancer	0.000174	0.00406	CbGpPWpGaD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—SULT1A1—breast cancer	0.000173	0.00405	CbGpPWpGaD
Dofetilide—Abdominal pain—Thiotepa—breast cancer	0.000173	0.000728	CcSEcCtD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—breast cancer	0.000173	0.00403	CbGpPWpGaD
Dofetilide—Headache—Vinblastine—breast cancer	0.000173	0.000727	CcSEcCtD
Dofetilide—Angioedema—Paclitaxel—breast cancer	0.000172	0.000726	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000172	0.000725	CcSEcCtD
Dofetilide—CYP3A4—endocrine gland—breast cancer	0.000171	0.0175	CbGeAlD
Dofetilide—CYP3A4—Estrogen metabolism—NQO1—breast cancer	0.000171	0.00399	CbGpPWpGaD
Dofetilide—Insomnia—Irinotecan—breast cancer	0.000171	0.000719	CcSEcCtD
Dofetilide—Cardiac arrest—Epirubicin—breast cancer	0.00017	0.000717	CcSEcCtD
Dofetilide—Cardiac failure—Doxorubicin—breast cancer	0.00017	0.000715	CcSEcCtD
Dofetilide—Paraesthesia—Mitoxantrone—breast cancer	0.000169	0.000714	CcSEcCtD
Dofetilide—Paraesthesia—Irinotecan—breast cancer	0.000169	0.000714	CcSEcCtD
Dofetilide—Syncope—Paclitaxel—breast cancer	0.000169	0.000713	CcSEcCtD
Dofetilide—Cerebrovascular accident—Doxorubicin—breast cancer	0.000169	0.000712	CcSEcCtD
Dofetilide—Dizziness—Goserelin—breast cancer	0.000169	0.000712	CcSEcCtD
Dofetilide—Rash—Tamoxifen—breast cancer	0.000169	0.000711	CcSEcCtD
Dofetilide—Dermatitis—Tamoxifen—breast cancer	0.000169	0.00071	CcSEcCtD
Dofetilide—Dyspnoea—Irinotecan—breast cancer	0.000168	0.000709	CcSEcCtD
Dofetilide—Dyspnoea—Mitoxantrone—breast cancer	0.000168	0.000709	CcSEcCtD
Dofetilide—Headache—Tamoxifen—breast cancer	0.000168	0.000706	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000168	0.000706	CcSEcCtD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP2D6—breast cancer	0.000167	0.0039	CbGpPWpGaD
Dofetilide—Palpitations—Paclitaxel—breast cancer	0.000167	0.000702	CcSEcCtD
Dofetilide—Insomnia—Gemcitabine—breast cancer	0.000166	0.000701	CcSEcCtD
Dofetilide—Loss of consciousness—Paclitaxel—breast cancer	0.000166	0.000699	CcSEcCtD
Dofetilide—Rash—Melphalan—breast cancer	0.000165	0.000696	CcSEcCtD
Dofetilide—Paraesthesia—Gemcitabine—breast cancer	0.000165	0.000696	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—ALDH1A1—breast cancer	0.000165	0.00386	CbGpPWpGaD
Dofetilide—Dermatitis—Melphalan—breast cancer	0.000165	0.000695	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000165	0.000694	CcSEcCtD
Dofetilide—Cough—Paclitaxel—breast cancer	0.000165	0.000694	CcSEcCtD
Dofetilide—Asthenia—Vinorelbine—breast cancer	0.000164	0.000692	CcSEcCtD
Dofetilide—Arrhythmia—Docetaxel—breast cancer	0.000164	0.000691	CcSEcCtD
Dofetilide—Dyspnoea—Gemcitabine—breast cancer	0.000164	0.000691	CcSEcCtD
Dofetilide—CYP3A4—Estrogen metabolism—CYP1B1—breast cancer	0.000164	0.00383	CbGpPWpGaD
Dofetilide—Nausea—Vinblastine—breast cancer	0.000164	0.000689	CcSEcCtD
Dofetilide—Insomnia—Fluorouracil—breast cancer	0.000164	0.000689	CcSEcCtD
Dofetilide—Migraine—Doxorubicin—breast cancer	0.000163	0.000687	CcSEcCtD
Dofetilide—Hypertension—Paclitaxel—breast cancer	0.000163	0.000686	CcSEcCtD
Dofetilide—Paraesthesia—Fluorouracil—breast cancer	0.000162	0.000684	CcSEcCtD
Dofetilide—Pain—Irinotecan—breast cancer	0.000161	0.00068	CcSEcCtD
Dofetilide—Pain—Mitoxantrone—breast cancer	0.000161	0.00068	CcSEcCtD
Dofetilide—Dyspnoea—Fluorouracil—breast cancer	0.000161	0.000679	CcSEcCtD
Dofetilide—Rash—Goserelin—breast cancer	0.000161	0.000679	CcSEcCtD
Dofetilide—Dermatitis—Goserelin—breast cancer	0.000161	0.000678	CcSEcCtD
Dofetilide—Arthralgia—Paclitaxel—breast cancer	0.000161	0.000677	CcSEcCtD
Dofetilide—Chest pain—Paclitaxel—breast cancer	0.000161	0.000677	CcSEcCtD
Dofetilide—Headache—Goserelin—breast cancer	0.00016	0.000675	CcSEcCtD
Dofetilide—Anxiety—Paclitaxel—breast cancer	0.00016	0.000674	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—GATA3—breast cancer	0.00016	0.00374	CbGpPWpGaD
Dofetilide—Nausea—Tamoxifen—breast cancer	0.000159	0.00067	CcSEcCtD
Dofetilide—Arrhythmia—Capecitabine—breast cancer	0.000159	0.000669	CcSEcCtD
Dofetilide—Cardiac arrest—Doxorubicin—breast cancer	0.000158	0.000664	CcSEcCtD
Dofetilide—Pain—Gemcitabine—breast cancer	0.000157	0.000663	CcSEcCtD
Dofetilide—Asthenia—Thiotepa—breast cancer	0.000157	0.000661	CcSEcCtD
Dofetilide—Diarrhoea—Vinorelbine—breast cancer	0.000157	0.00066	CcSEcCtD
Dofetilide—Nausea—Melphalan—breast cancer	0.000156	0.000656	CcSEcCtD
Dofetilide—Influenza—Epirubicin—breast cancer	0.000155	0.000652	CcSEcCtD
Dofetilide—Back pain—Docetaxel—breast cancer	0.000155	0.000652	CcSEcCtD
Dofetilide—Pain—Fluorouracil—breast cancer	0.000155	0.000651	CcSEcCtD
Dofetilide—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000154	0.00065	CcSEcCtD
Dofetilide—Gastrointestinal pain—Irinotecan—breast cancer	0.000154	0.00065	CcSEcCtD
Dofetilide—Oedema—Paclitaxel—breast cancer	0.000154	0.000649	CcSEcCtD
Dofetilide—Nausea—Goserelin—breast cancer	0.000152	0.00064	CcSEcCtD
Dofetilide—Shock—Paclitaxel—breast cancer	0.000151	0.000638	CcSEcCtD
Dofetilide—Dizziness—Vinorelbine—breast cancer	0.000151	0.000638	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—MDM2—breast cancer	0.000151	0.00354	CbGpPWpGaD
Dofetilide—Angina pectoris—Epirubicin—breast cancer	0.000151	0.000635	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—RAF1—breast cancer	0.000151	0.00352	CbGpPWpGaD
Dofetilide—Back pain—Capecitabine—breast cancer	0.00015	0.000631	CcSEcCtD
Dofetilide—Diarrhoea—Thiotepa—breast cancer	0.00015	0.00063	CcSEcCtD
Dofetilide—Abdominal pain—Mitoxantrone—breast cancer	0.000149	0.000629	CcSEcCtD
Dofetilide—Abdominal pain—Irinotecan—breast cancer	0.000149	0.000629	CcSEcCtD
Dofetilide—Hyperhidrosis—Paclitaxel—breast cancer	0.000149	0.000627	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—breast cancer	0.000146	0.00341	CbGpPWpGaD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP1B1—breast cancer	0.000145	0.00338	CbGpPWpGaD
Dofetilide—Dizziness—Thiotepa—breast cancer	0.000145	0.000609	CcSEcCtD
Dofetilide—Rash—Vinorelbine—breast cancer	0.000144	0.000608	CcSEcCtD
Dofetilide—Dermatitis—Vinorelbine—breast cancer	0.000144	0.000608	CcSEcCtD
Dofetilide—KCNJ12—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—breast cancer	0.000144	0.00337	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—ESR2—breast cancer	0.000143	0.00335	CbGpPWpGaD
Dofetilide—Headache—Vinorelbine—breast cancer	0.000143	0.000604	CcSEcCtD
Dofetilide—Syncope—Docetaxel—breast cancer	0.000143	0.000604	CcSEcCtD
Dofetilide—Influenza—Doxorubicin—breast cancer	0.000143	0.000603	CcSEcCtD
Dofetilide—CYP3A4—Estrogen metabolism—COMT—breast cancer	0.000143	0.00335	CbGpPWpGaD
Dofetilide—Sweating—Methotrexate—breast cancer	0.000141	0.000596	CcSEcCtD
Dofetilide—Palpitations—Docetaxel—breast cancer	0.000141	0.000595	CcSEcCtD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—breast cancer	0.000141	0.0033	CbGpPWpGaD
Dofetilide—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—breast cancer	0.000141	0.00329	CbGpPWpGaD
Dofetilide—Loss of consciousness—Docetaxel—breast cancer	0.000141	0.000592	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.00014	0.000591	CcSEcCtD
Dofetilide—Cough—Docetaxel—breast cancer	0.00014	0.000588	CcSEcCtD
Dofetilide—Angina pectoris—Doxorubicin—breast cancer	0.000139	0.000588	CcSEcCtD
Dofetilide—Insomnia—Paclitaxel—breast cancer	0.000139	0.000587	CcSEcCtD
Dofetilide—Syncope—Capecitabine—breast cancer	0.000139	0.000585	CcSEcCtD
Dofetilide—Paraesthesia—Paclitaxel—breast cancer	0.000138	0.000582	CcSEcCtD
Dofetilide—Hypertension—Docetaxel—breast cancer	0.000138	0.000582	CcSEcCtD
Dofetilide—Rash—Thiotepa—breast cancer	0.000138	0.000581	CcSEcCtD
Dofetilide—Dermatitis—Thiotepa—breast cancer	0.000138	0.00058	CcSEcCtD
Dofetilide—Dyspnoea—Paclitaxel—breast cancer	0.000137	0.000578	CcSEcCtD
Dofetilide—Headache—Thiotepa—breast cancer	0.000137	0.000577	CcSEcCtD
Dofetilide—Palpitations—Capecitabine—breast cancer	0.000137	0.000576	CcSEcCtD
Dofetilide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—breast cancer	0.000136	0.00319	CbGpPWpGaD
Dofetilide—Chest pain—Docetaxel—breast cancer	0.000136	0.000574	CcSEcCtD
Dofetilide—Arthralgia—Docetaxel—breast cancer	0.000136	0.000574	CcSEcCtD
Dofetilide—Loss of consciousness—Capecitabine—breast cancer	0.000136	0.000573	CcSEcCtD
Dofetilide—Nausea—Vinorelbine—breast cancer	0.000136	0.000573	CcSEcCtD
Dofetilide—Asthenia—Mitoxantrone—breast cancer	0.000135	0.000571	CcSEcCtD
Dofetilide—Asthenia—Irinotecan—breast cancer	0.000135	0.000571	CcSEcCtD
Dofetilide—Cough—Capecitabine—breast cancer	0.000135	0.000569	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—EGR1—breast cancer	0.000134	0.00314	CbGpPWpGaD
Dofetilide—Urinary tract infection—Epirubicin—breast cancer	0.000134	0.000565	CcSEcCtD
Dofetilide—Hypertension—Capecitabine—breast cancer	0.000134	0.000563	CcSEcCtD
Dofetilide—Sweating—Epirubicin—breast cancer	0.000132	0.000557	CcSEcCtD
Dofetilide—Asthenia—Gemcitabine—breast cancer	0.000132	0.000556	CcSEcCtD
Dofetilide—Arthralgia—Capecitabine—breast cancer	0.000132	0.000555	CcSEcCtD
Dofetilide—Chest pain—Capecitabine—breast cancer	0.000132	0.000555	CcSEcCtD
Dofetilide—Pain—Paclitaxel—breast cancer	0.000132	0.000555	CcSEcCtD
Dofetilide—Anxiety—Capecitabine—breast cancer	0.000131	0.000553	CcSEcCtD
Dofetilide—CYP3A4—Estrogen metabolism—GSTM1—breast cancer	0.000131	0.00306	CbGpPWpGaD
Dofetilide—Oedema—Docetaxel—breast cancer	0.00013	0.00055	CcSEcCtD
Dofetilide—Nausea—Thiotepa—breast cancer	0.00013	0.000547	CcSEcCtD
Dofetilide—Diarrhoea—Irinotecan—breast cancer	0.000129	0.000544	CcSEcCtD
Dofetilide—Diarrhoea—Mitoxantrone—breast cancer	0.000129	0.000544	CcSEcCtD
Dofetilide—Shock—Docetaxel—breast cancer	0.000128	0.000541	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—AR—breast cancer	0.000127	0.00296	CbGpPWpGaD
Dofetilide—Oedema—Capecitabine—breast cancer	0.000126	0.000532	CcSEcCtD
Dofetilide—Bradycardia—Epirubicin—breast cancer	0.000126	0.000531	CcSEcCtD
Dofetilide—Gastrointestinal pain—Paclitaxel—breast cancer	0.000126	0.00053	CcSEcCtD
Dofetilide—Diarrhoea—Gemcitabine—breast cancer	0.000126	0.00053	CcSEcCtD
Dofetilide—Dizziness—Irinotecan—breast cancer	0.000125	0.000526	CcSEcCtD
Dofetilide—Shock—Capecitabine—breast cancer	0.000124	0.000524	CcSEcCtD
Dofetilide—Urinary tract infection—Doxorubicin—breast cancer	0.000124	0.000523	CcSEcCtD
Dofetilide—CYP3A4—Estrogen metabolism—CYP1A1—breast cancer	0.000124	0.0029	CbGpPWpGaD
Dofetilide—Diarrhoea—Fluorouracil—breast cancer	0.000124	0.000521	CcSEcCtD
Dofetilide—Sweating—Doxorubicin—breast cancer	0.000122	0.000516	CcSEcCtD
Dofetilide—Hyperhidrosis—Capecitabine—breast cancer	0.000122	0.000515	CcSEcCtD
Dofetilide—Oedema peripheral—Epirubicin—breast cancer	0.000122	0.000514	CcSEcCtD
Dofetilide—Abdominal pain—Paclitaxel—breast cancer	0.000122	0.000513	CcSEcCtD
Dofetilide—Dizziness—Fluorouracil—breast cancer	0.00012	0.000504	CcSEcCtD
Dofetilide—Rash—Irinotecan—breast cancer	0.000119	0.000501	CcSEcCtD
Dofetilide—Rash—Mitoxantrone—breast cancer	0.000119	0.000501	CcSEcCtD
Dofetilide—Dermatitis—Mitoxantrone—breast cancer	0.000119	0.000501	CcSEcCtD
Dofetilide—Dermatitis—Irinotecan—breast cancer	0.000119	0.000501	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000119	0.000501	CcSEcCtD
Dofetilide—CYP3A4—Irinotecan Pathway—APC—breast cancer	0.000119	0.00278	CbGpPWpGaD
Dofetilide—Headache—Mitoxantrone—breast cancer	0.000118	0.000498	CcSEcCtD
Dofetilide—Headache—Irinotecan—breast cancer	0.000118	0.000498	CcSEcCtD
Dofetilide—Insomnia—Docetaxel—breast cancer	0.000118	0.000497	CcSEcCtD
Dofetilide—Paraesthesia—Docetaxel—breast cancer	0.000117	0.000494	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA2—breast cancer	0.000117	0.00274	CbGpPWpGaD
Dofetilide—Bradycardia—Doxorubicin—breast cancer	0.000117	0.000492	CcSEcCtD
Dofetilide—Dyspnoea—Docetaxel—breast cancer	0.000116	0.00049	CcSEcCtD
Dofetilide—Rash—Gemcitabine—breast cancer	0.000116	0.000489	CcSEcCtD
Dofetilide—Dermatitis—Gemcitabine—breast cancer	0.000116	0.000488	CcSEcCtD
Dofetilide—Headache—Gemcitabine—breast cancer	0.000115	0.000485	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000115	0.000485	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—BRAF—breast cancer	0.000115	0.00268	CbGpPWpGaD
Dofetilide—Insomnia—Capecitabine—breast cancer	0.000114	0.000481	CcSEcCtD
Dofetilide—CYP3A4—Xenobiotics—CYP1A1—breast cancer	0.000114	0.00267	CbGpPWpGaD
Dofetilide—Rash—Fluorouracil—breast cancer	0.000114	0.00048	CcSEcCtD
Dofetilide—Dermatitis—Fluorouracil—breast cancer	0.000114	0.00048	CcSEcCtD
Dofetilide—Paraesthesia—Capecitabine—breast cancer	0.000113	0.000478	CcSEcCtD
Dofetilide—Headache—Fluorouracil—breast cancer	0.000113	0.000477	CcSEcCtD
Dofetilide—Oedema peripheral—Doxorubicin—breast cancer	0.000113	0.000476	CcSEcCtD
Dofetilide—Dyspnoea—Capecitabine—breast cancer	0.000113	0.000475	CcSEcCtD
Dofetilide—Nausea—Mitoxantrone—breast cancer	0.000112	0.000472	CcSEcCtD
Dofetilide—Nausea—Irinotecan—breast cancer	0.000112	0.000472	CcSEcCtD
Dofetilide—Pain—Docetaxel—breast cancer	0.000112	0.00047	CcSEcCtD
Dofetilide—Back pain—Methotrexate—breast cancer	0.000111	0.00047	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HES1—breast cancer	0.000111	0.0026	CbGpPWpGaD
Dofetilide—Arrhythmia—Epirubicin—breast cancer	0.000111	0.000466	CcSEcCtD
Dofetilide—Asthenia—Paclitaxel—breast cancer	0.00011	0.000465	CcSEcCtD
Dofetilide—CYP3A4—Tamoxifen metabolism—CYP1A1—breast cancer	0.00011	0.00256	CbGpPWpGaD
Dofetilide—Nausea—Gemcitabine—breast cancer	0.000109	0.00046	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—ACHE—breast cancer	0.000109	0.00255	CbGpPWpGaD
Dofetilide—KCNJ12—Transmission across Chemical Synapses—HRAS—breast cancer	0.000108	0.00253	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—breast cancer	0.000108	0.00253	CbGpPWpGaD
Dofetilide—Pain—Capecitabine—breast cancer	0.000108	0.000455	CcSEcCtD
Dofetilide—Nausea—Fluorouracil—breast cancer	0.000107	0.000452	CcSEcCtD
Dofetilide—Gastrointestinal pain—Docetaxel—breast cancer	0.000107	0.00045	CcSEcCtD
Dofetilide—Diarrhoea—Paclitaxel—breast cancer	0.000105	0.000444	CcSEcCtD
Dofetilide—Back pain—Epirubicin—breast cancer	0.000104	0.00044	CcSEcCtD
Dofetilide—Gastrointestinal pain—Capecitabine—breast cancer	0.000103	0.000435	CcSEcCtD
Dofetilide—Abdominal pain—Docetaxel—breast cancer	0.000103	0.000435	CcSEcCtD
Dofetilide—Arrhythmia—Doxorubicin—breast cancer	0.000102	0.000431	CcSEcCtD
Dofetilide—Dizziness—Paclitaxel—breast cancer	0.000102	0.000429	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—HSP90AA1—breast cancer	0.000101	0.00237	CbGpPWpGaD
Dofetilide—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—breast cancer	0.000101	0.00236	CbGpPWpGaD
Dofetilide—Cough—Methotrexate—breast cancer	0.000101	0.000424	CcSEcCtD
Dofetilide—Abdominal pain—Capecitabine—breast cancer	9.99e-05	0.000421	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—breast cancer	9.86e-05	0.00231	CbGpPWpGaD
Dofetilide—Arthralgia—Methotrexate—breast cancer	9.81e-05	0.000413	CcSEcCtD
Dofetilide—Chest pain—Methotrexate—breast cancer	9.81e-05	0.000413	CcSEcCtD
Dofetilide—Rash—Paclitaxel—breast cancer	9.71e-05	0.000409	CcSEcCtD
Dofetilide—Dermatitis—Paclitaxel—breast cancer	9.7e-05	0.000409	CcSEcCtD
Dofetilide—Syncope—Epirubicin—breast cancer	9.67e-05	0.000407	CcSEcCtD
Dofetilide—Back pain—Doxorubicin—breast cancer	9.65e-05	0.000407	CcSEcCtD
Dofetilide—Headache—Paclitaxel—breast cancer	9.64e-05	0.000406	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—MDM2—breast cancer	9.61e-05	0.00225	CbGpPWpGaD
Dofetilide—KCNK2—Neuronal System—RAF1—breast cancer	9.57e-05	0.00224	CbGpPWpGaD
Dofetilide—Palpitations—Epirubicin—breast cancer	9.53e-05	0.000402	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—BCHE—breast cancer	9.51e-05	0.00222	CbGpPWpGaD
Dofetilide—Loss of consciousness—Epirubicin—breast cancer	9.48e-05	0.000399	CcSEcCtD
Dofetilide—Cough—Epirubicin—breast cancer	9.41e-05	0.000397	CcSEcCtD
Dofetilide—Asthenia—Docetaxel—breast cancer	9.36e-05	0.000394	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—HIF1A—breast cancer	9.33e-05	0.00218	CbGpPWpGaD
Dofetilide—Hypertension—Epirubicin—breast cancer	9.31e-05	0.000392	CcSEcCtD
Dofetilide—Arthralgia—Epirubicin—breast cancer	9.18e-05	0.000387	CcSEcCtD
Dofetilide—Chest pain—Epirubicin—breast cancer	9.18e-05	0.000387	CcSEcCtD
Dofetilide—Anxiety—Epirubicin—breast cancer	9.15e-05	0.000386	CcSEcCtD
Dofetilide—Nausea—Paclitaxel—breast cancer	9.14e-05	0.000385	CcSEcCtD
Dofetilide—Hyperhidrosis—Methotrexate—breast cancer	9.09e-05	0.000383	CcSEcCtD
Dofetilide—Asthenia—Capecitabine—breast cancer	9.06e-05	0.000382	CcSEcCtD
Dofetilide—Syncope—Doxorubicin—breast cancer	8.95e-05	0.000377	CcSEcCtD
Dofetilide—Diarrhoea—Docetaxel—breast cancer	8.93e-05	0.000376	CcSEcCtD
Dofetilide—Palpitations—Doxorubicin—breast cancer	8.82e-05	0.000372	CcSEcCtD
Dofetilide—Oedema—Epirubicin—breast cancer	8.8e-05	0.000371	CcSEcCtD
Dofetilide—Loss of consciousness—Doxorubicin—breast cancer	8.77e-05	0.00037	CcSEcCtD
Dofetilide—Cough—Doxorubicin—breast cancer	8.71e-05	0.000367	CcSEcCtD
Dofetilide—Shock—Epirubicin—breast cancer	8.66e-05	0.000365	CcSEcCtD
Dofetilide—Diarrhoea—Capecitabine—breast cancer	8.64e-05	0.000364	CcSEcCtD
Dofetilide—Dizziness—Docetaxel—breast cancer	8.63e-05	0.000364	CcSEcCtD
Dofetilide—Hypertension—Doxorubicin—breast cancer	8.61e-05	0.000363	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Methotrexate—breast cancer	8.57e-05	0.000361	CcSEcCtD
Dofetilide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—breast cancer	8.51e-05	0.00199	CbGpPWpGaD
Dofetilide—Hyperhidrosis—Epirubicin—breast cancer	8.51e-05	0.000359	CcSEcCtD
Dofetilide—Insomnia—Methotrexate—breast cancer	8.51e-05	0.000358	CcSEcCtD
Dofetilide—Arthralgia—Doxorubicin—breast cancer	8.5e-05	0.000358	CcSEcCtD
Dofetilide—Chest pain—Doxorubicin—breast cancer	8.5e-05	0.000358	CcSEcCtD
Dofetilide—Anxiety—Doxorubicin—breast cancer	8.47e-05	0.000357	CcSEcCtD
Dofetilide—Paraesthesia—Methotrexate—breast cancer	8.44e-05	0.000356	CcSEcCtD
Dofetilide—Dyspnoea—Methotrexate—breast cancer	8.38e-05	0.000353	CcSEcCtD
Dofetilide—Dizziness—Capecitabine—breast cancer	8.35e-05	0.000352	CcSEcCtD
Dofetilide—KCNJ12—Neuronal System—HRAS—breast cancer	8.3e-05	0.00194	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CHST9—breast cancer	8.27e-05	0.00193	CbGpPWpGaD
Dofetilide—Rash—Docetaxel—breast cancer	8.23e-05	0.000347	CcSEcCtD
Dofetilide—Dermatitis—Docetaxel—breast cancer	8.22e-05	0.000346	CcSEcCtD
Dofetilide—Headache—Docetaxel—breast cancer	8.17e-05	0.000344	CcSEcCtD
Dofetilide—Oedema—Doxorubicin—breast cancer	8.14e-05	0.000343	CcSEcCtD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—breast cancer	8.11e-05	0.0019	CbGpPWpGaD
Dofetilide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—breast cancer	8.09e-05	0.00189	CbGpPWpGaD
Dofetilide—Pain—Methotrexate—breast cancer	8.04e-05	0.000339	CcSEcCtD
Dofetilide—Musculoskeletal discomfort—Epirubicin—breast cancer	8.02e-05	0.000338	CcSEcCtD
Dofetilide—Shock—Doxorubicin—breast cancer	8.01e-05	0.000338	CcSEcCtD
Dofetilide—Rash—Capecitabine—breast cancer	7.97e-05	0.000336	CcSEcCtD
Dofetilide—Insomnia—Epirubicin—breast cancer	7.96e-05	0.000335	CcSEcCtD
Dofetilide—Dermatitis—Capecitabine—breast cancer	7.96e-05	0.000335	CcSEcCtD
Dofetilide—Headache—Capecitabine—breast cancer	7.91e-05	0.000333	CcSEcCtD
Dofetilide—Paraesthesia—Epirubicin—breast cancer	7.9e-05	0.000333	CcSEcCtD
Dofetilide—Hyperhidrosis—Doxorubicin—breast cancer	7.87e-05	0.000332	CcSEcCtD
Dofetilide—Dyspnoea—Epirubicin—breast cancer	7.85e-05	0.000331	CcSEcCtD
Dofetilide—Nausea—Docetaxel—breast cancer	7.75e-05	0.000327	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—CYP1B1—breast cancer	7.73e-05	0.00181	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Methotrexate—breast cancer	7.69e-05	0.000324	CcSEcCtD
Dofetilide—KCNH2—Neuronal System—COMT—breast cancer	7.61e-05	0.00178	CbGpPWpGaD
Dofetilide—Pain—Epirubicin—breast cancer	7.53e-05	0.000317	CcSEcCtD
Dofetilide—Nausea—Capecitabine—breast cancer	7.5e-05	0.000316	CcSEcCtD
Dofetilide—Abdominal pain—Methotrexate—breast cancer	7.43e-05	0.000313	CcSEcCtD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—breast cancer	7.43e-05	0.00174	CbGpPWpGaD
Dofetilide—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.42e-05	0.000313	CcSEcCtD
Dofetilide—Insomnia—Doxorubicin—breast cancer	7.37e-05	0.00031	CcSEcCtD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—breast cancer	7.33e-05	0.00171	CbGpPWpGaD
Dofetilide—Paraesthesia—Doxorubicin—breast cancer	7.31e-05	0.000308	CcSEcCtD
Dofetilide—CYP3A4—Tryptophan metabolism—CYP19A1—breast cancer	7.27e-05	0.0017	CbGpPWpGaD
Dofetilide—Dyspnoea—Doxorubicin—breast cancer	7.26e-05	0.000306	CcSEcCtD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—breast cancer	7.21e-05	0.00169	CbGpPWpGaD
Dofetilide—Gastrointestinal pain—Epirubicin—breast cancer	7.2e-05	0.000303	CcSEcCtD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—breast cancer	7.11e-05	0.00166	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	7.08e-05	0.00165	CbGpPWpGaD
Dofetilide—Pain—Doxorubicin—breast cancer	6.96e-05	0.000293	CcSEcCtD
Dofetilide—Abdominal pain—Epirubicin—breast cancer	6.96e-05	0.000293	CcSEcCtD
Dofetilide—Asthenia—Methotrexate—breast cancer	6.75e-05	0.000284	CcSEcCtD
Dofetilide—Gastrointestinal pain—Doxorubicin—breast cancer	6.66e-05	0.000281	CcSEcCtD
Dofetilide—Abdominal pain—Doxorubicin—breast cancer	6.44e-05	0.000271	CcSEcCtD
Dofetilide—Diarrhoea—Methotrexate—breast cancer	6.43e-05	0.000271	CcSEcCtD
Dofetilide—Asthenia—Epirubicin—breast cancer	6.31e-05	0.000266	CcSEcCtD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	6.25e-05	0.00146	CbGpPWpGaD
Dofetilide—Dizziness—Methotrexate—breast cancer	6.22e-05	0.000262	CcSEcCtD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—breast cancer	6.17e-05	0.00144	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CXCL8—breast cancer	6.06e-05	0.00142	CbGpPWpGaD
Dofetilide—Diarrhoea—Epirubicin—breast cancer	6.02e-05	0.000254	CcSEcCtD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	6.02e-05	0.00141	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	5.96e-05	0.00139	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	5.96e-05	0.00139	CbGpPWpGaD
Dofetilide—Rash—Methotrexate—breast cancer	5.93e-05	0.00025	CcSEcCtD
Dofetilide—Dermatitis—Methotrexate—breast cancer	5.92e-05	0.00025	CcSEcCtD
Dofetilide—Headache—Methotrexate—breast cancer	5.89e-05	0.000248	CcSEcCtD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	5.88e-05	0.00137	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—CYP1A1—breast cancer	5.86e-05	0.00137	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	5.84e-05	0.00137	CbGpPWpGaD
Dofetilide—Asthenia—Doxorubicin—breast cancer	5.84e-05	0.000246	CcSEcCtD
Dofetilide—Dizziness—Epirubicin—breast cancer	5.82e-05	0.000245	CcSEcCtD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL1B—breast cancer	5.81e-05	0.00136	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—breast cancer	5.8e-05	0.00136	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CASP3—breast cancer	5.8e-05	0.00136	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—ALDH1A1—breast cancer	5.75e-05	0.00134	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	5.74e-05	0.00134	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—JUN—breast cancer	5.63e-05	0.00132	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—CTNNB1—breast cancer	5.59e-05	0.00131	CbGpPWpGaD
Dofetilide—Nausea—Methotrexate—breast cancer	5.59e-05	0.000235	CcSEcCtD
Dofetilide—Diarrhoea—Doxorubicin—breast cancer	5.57e-05	0.000235	CcSEcCtD
Dofetilide—Rash—Epirubicin—breast cancer	5.55e-05	0.000234	CcSEcCtD
Dofetilide—Dermatitis—Epirubicin—breast cancer	5.54e-05	0.000234	CcSEcCtD
Dofetilide—Headache—Epirubicin—breast cancer	5.51e-05	0.000232	CcSEcCtD
Dofetilide—Dizziness—Doxorubicin—breast cancer	5.39e-05	0.000227	CcSEcCtD
Dofetilide—KCNK2—Neuronal System—HRAS—breast cancer	5.27e-05	0.00123	CbGpPWpGaD
Dofetilide—Nausea—Epirubicin—breast cancer	5.23e-05	0.00022	CcSEcCtD
Dofetilide—Rash—Doxorubicin—breast cancer	5.13e-05	0.000216	CcSEcCtD
Dofetilide—Dermatitis—Doxorubicin—breast cancer	5.13e-05	0.000216	CcSEcCtD
Dofetilide—CYP3A4—Biological oxidations—GSTA3—breast cancer	5.12e-05	0.0012	CbGpPWpGaD
Dofetilide—Headache—Doxorubicin—breast cancer	5.1e-05	0.000215	CcSEcCtD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	5.07e-05	0.00118	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTA3—breast cancer	5.05e-05	0.00118	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—VEGFA—breast cancer	4.92e-05	0.00115	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—BRAF—breast cancer	4.86e-05	0.00114	CbGpPWpGaD
Dofetilide—Nausea—Doxorubicin—breast cancer	4.84e-05	0.000204	CcSEcCtD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	4.83e-05	0.00113	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	4.76e-05	0.00111	CbGpPWpGaD
Dofetilide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	4.74e-05	0.00111	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTA4—breast cancer	4.69e-05	0.0011	CbGpPWpGaD
Dofetilide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—breast cancer	4.67e-05	0.00109	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTA4—breast cancer	4.62e-05	0.00108	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTA2—breast cancer	4.57e-05	0.00107	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—SULT1A1—breast cancer	4.51e-05	0.00105	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GPX2—breast cancer	4.5e-05	0.00105	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GPX4—breast cancer	4.45e-05	0.00104	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—SULT1A1—breast cancer	4.45e-05	0.00104	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTA1—breast cancer	4.41e-05	0.00103	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—NAT2—breast cancer	4.36e-05	0.00102	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—NAT2—breast cancer	4.3e-05	0.001	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—TNF—breast cancer	4.22e-05	0.000986	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—MDM2—breast cancer	4.07e-05	0.000951	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—RAF1—breast cancer	4.05e-05	0.000948	CbGpPWpGaD
Dofetilide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	3.84e-05	0.000898	CbGpPWpGaD
Dofetilide—CYP3A4—Tryptophan metabolism—MDM2—breast cancer	3.61e-05	0.000845	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—MTR—breast cancer	3.55e-05	0.00083	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—HPGDS—breast cancer	3.48e-05	0.000814	CbGpPWpGaD
Dofetilide—KCNH2—SIDS Susceptibility Pathways—IL6—breast cancer	3.4e-05	0.000795	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTT1—breast cancer	3.38e-05	0.00079	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP17A1—breast cancer	3.2e-05	0.000748	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—PTGS1—breast cancer	3.17e-05	0.00074	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP17A1—breast cancer	3.15e-05	0.000737	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP2D6—breast cancer	3.1e-05	0.000726	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP2D6—breast cancer	3.06e-05	0.000716	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—NCOA2—breast cancer	3.05e-05	0.000712	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP1B1—breast cancer	2.69e-05	0.000629	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	2.65e-05	0.000621	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—NCOA1—breast cancer	2.57e-05	0.0006	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP19A1—breast cancer	2.53e-05	0.000592	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	2.5e-05	0.000584	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—COMT—breast cancer	2.35e-05	0.00055	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTP1—breast cancer	2.34e-05	0.000547	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—COMT—breast cancer	2.32e-05	0.000542	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	2.31e-05	0.00054	CbGpPWpGaD
Dofetilide—KCNH2—Neuronal System—HRAS—breast cancer	2.23e-05	0.000522	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—GSTM1—breast cancer	2.15e-05	0.000503	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	2.12e-05	0.000496	CbGpPWpGaD
Dofetilide—CYP3A4—Biological oxidations—CYP1A1—breast cancer	2.04e-05	0.000477	CbGpPWpGaD
Dofetilide—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	2.01e-05	0.00047	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SYNJ2—breast cancer	1.64e-05	0.000384	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NDUFS3—breast cancer	1.53e-05	0.000357	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CHST9—breast cancer	1.43e-05	0.000335	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—COX11—breast cancer	1.36e-05	0.000318	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CDA—breast cancer	1.24e-05	0.000291	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SHMT1—breast cancer	1.24e-05	0.000291	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC2A5—breast cancer	1.2e-05	0.00028	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.2e-05	0.00028	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—APRT—breast cancer	1.16e-05	0.00027	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ESRRA—breast cancer	1.09e-05	0.000254	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.09e-05	0.000254	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPI—breast cancer	1.03e-05	0.000241	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HADHB—breast cancer	1.03e-05	0.000241	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALDH7A1—breast cancer	9.83e-06	0.00023	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALDH1A1—breast cancer	9.83e-06	0.00023	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—FHL2—breast cancer	9.42e-06	0.00022	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NME1—breast cancer	9.42e-06	0.00022	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PHGDH—breast cancer	9.42e-06	0.00022	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—UMPS—breast cancer	9.42e-06	0.00022	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ADSL—breast cancer	9.42e-06	0.00022	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—LDHB—breast cancer	9.24e-06	0.000216	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—BRIP1—breast cancer	9.24e-06	0.000216	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HPSE—breast cancer	9.24e-06	0.000216	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTA3—breast cancer	8.76e-06	0.000205	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HMMR—breast cancer	8.76e-06	0.000205	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCC1—breast cancer	8.76e-06	0.000205	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PPARGC1B—breast cancer	8.49e-06	0.000198	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTA4—breast cancer	8.01e-06	0.000187	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CA9—breast cancer	8.01e-06	0.000187	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTA2—breast cancer	7.81e-06	0.000183	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPX2—breast cancer	7.81e-06	0.000183	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPX4—breast cancer	7.71e-06	0.00018	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SULT1A1—breast cancer	7.71e-06	0.00018	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTA1—breast cancer	7.53e-06	0.000176	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—IDH1—breast cancer	7.53e-06	0.000176	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NAT2—breast cancer	7.45e-06	0.000174	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MED12—breast cancer	6.53e-06	0.000153	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—DPYD—breast cancer	6.53e-06	0.000153	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALDOA—breast cancer	6.43e-06	0.00015	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NCOA3—breast cancer	6.24e-06	0.000146	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC2A2—breast cancer	6.2e-06	0.000145	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCG2—breast cancer	6.07e-06	0.000142	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CPT1A—breast cancer	6.07e-06	0.000142	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MTR—breast cancer	6.07e-06	0.000142	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HPGDS—breast cancer	5.96e-06	0.000139	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HBA1—breast cancer	5.92e-06	0.000138	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ACHE—breast cancer	5.78e-06	0.000135	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTT1—breast cancer	5.78e-06	0.000135	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP17A1—breast cancer	5.47e-06	0.000128	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTGS1—breast cancer	5.41e-06	0.000127	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ENO1—breast cancer	5.41e-06	0.000127	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP2D6—breast cancer	5.31e-06	0.000124	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NCOA2—breast cancer	5.21e-06	0.000122	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—FASN—breast cancer	5.05e-06	0.000118	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—BCHE—breast cancer	5.03e-06	0.000118	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC5A5—breast cancer	4.97e-06	0.000116	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NQO1—breast cancer	4.8e-06	0.000112	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—SLC2A1—breast cancer	4.8e-06	0.000112	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP1B1—breast cancer	4.6e-06	0.000108	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.51e-06	0.000106	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NCOA1—breast cancer	4.39e-06	0.000103	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—STK11—breast cancer	4.33e-06	0.000101	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP19A1—breast cancer	4.33e-06	0.000101	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—COMT—breast cancer	4.02e-06	9.41e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTP1—breast cancer	4e-06	9.36e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—HMOX1—breast cancer	3.95e-06	9.23e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ITPR1—breast cancer	3.94e-06	9.21e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ABCB1—breast cancer	3.79e-06	8.86e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—TYMS—breast cancer	3.72e-06	8.7e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GSTM1—breast cancer	3.68e-06	8.6e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.68e-06	8.6e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NCOR1—breast cancer	3.68e-06	8.6e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—GPX1—breast cancer	3.52e-06	8.24e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CYP1A1—breast cancer	3.49e-06	8.16e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ERCC2—breast cancer	3.46e-06	8.09e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—MTHFR—breast cancer	3.25e-06	7.6e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—CAV1—breast cancer	3e-06	7.01e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CG—breast cancer	2.73e-06	6.39e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CD—breast cancer	2.4e-06	5.62e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—ALB—breast cancer	2.37e-06	5.54e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—NOS3—breast cancer	2.27e-06	5.3e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CB—breast cancer	2.09e-06	4.9e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTGS2—breast cancer	2.07e-06	4.85e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PTEN—breast cancer	1.81e-06	4.23e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—PIK3CA—breast cancer	1.28e-06	2.98e-05	CbGpPWpGaD
Dofetilide—CYP3A4—Metabolism—AKT1—breast cancer	1.04e-06	2.44e-05	CbGpPWpGaD
